跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
高 智飛
副教授
國立陽明交通大學
智慧型藥物與智能生物裝置研究中心
https://orcid.org/0000-0002-2723-1111
h-index
h10-index
h5-index
324
引文
6
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
20
引文
3
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
20
引文
3
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2003
2024
每年研究成果
概覽
指紋
網路
計畫
(10)
研究成果
(8)
類似的個人檔案
(6)
指紋
查看啟用 Chih-Fei Kao 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Hepatitis C Virus Core Protein
100%
Gene Expression
50%
Drosophilidae
50%
Transcription Factor
27%
Nitric Oxide Delivery
25%
Gene Replication
25%
Anticancer Treatment
25%
RNA Polymerase I Transcription
25%
Tumor Model
25%
Alzheimer's Disease
25%
Brain Aging
25%
Nitric Oxide
25%
Neurobiology
25%
SARS-CoV-2 Spike Glycoprotein
25%
Dinitrosyl Iron Complexes
25%
Neuroprotective Effect
25%
Amyloid Pathology
25%
Neural Development
25%
Aging Brain
25%
Degenerative Disease
25%
Drosophila Genetics
25%
Virus Gene
25%
Post-translational Modification
25%
Hepatitis B Virus
25%
Regulatory Activity
25%
Coactivator
25%
Hepatitis C Virus Core
25%
Phosphoprotein
25%
Nucleolar
25%
P300
25%
Hydrothermally
25%
Recombinant
25%
Electrochemical Biosensor
25%
Older Adults
25%
Point-of-care
25%
Social Perception
25%
Biosensor chip
25%
COVID-19
25%
Metal-organic Frameworks (MOFs)
25%
Point-of-care Diagnostics
25%
Viral Antigens
25%
Pseudovirus
25%
Nanohybrid
25%
A.aegypti
18%
Hepatitis C Virus
15%
Human Communities
12%
MOF Nanocomposites
12%
Global Catastrophe
12%
Point-of-care Diagnostic Tests
12%
Omicron BA.2
12%
Biochemistry, Genetics and Molecular Biology
Virus Core
100%
Hepatitis C Virus
100%
Transcription
56%
Gene Expression
50%
RNA Polymerase I
27%
Gene Replication
25%
Phosphoprotein
25%
YY1
25%
Genetics
25%
Perception
25%
P53
25%
Hepatitis B Virus
25%
Virus Gene
25%
Posttranslational Modification
25%
Lifespan
25%
Promoter Region
12%
Polymerase
8%
Complex Formation
8%
TATA-binding Protein
5%
Ribosomal RNA
5%
Immunology and Microbiology
Hepatitis C Virus
75%
Virus Core
75%
Gene Expression
50%
Hepatitis B Virus
25%
Aedes aegypti
25%
Salivary Gland
25%
RNA Polymerase
25%
C-Type Lectin
25%
Dengue Virus
25%
Viral Disease
25%
Virus Gene
25%
Gene Replication
25%
Promoter Region
16%
Complex Formation
11%
Viral Replication
7%
Carboxy Terminal Sequence
6%
Pleiotropy
6%
DNA Responsive Element
6%
TATA Binding Protein
6%
